rs746538436
Variant names:
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_032380.5(GFM2):c.636delA(p.Glu213ArgfsTer3) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000144 in 1,392,692 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
GFM2
NM_032380.5 frameshift
NM_032380.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.334
Publications
3 publications found
Genes affected
GFM2 (HGNC:29682): (GTP dependent ribosome recycling factor mitochondrial 2) Eukaryotes contain two protein translational systems, one in the cytoplasm and one in the mitochondria. Mitochondrial translation is crucial for maintaining mitochondrial function and mutations in this system lead to a breakdown in the respiratory chain-oxidative phosphorylation system and to impaired maintenance of mitochondrial DNA. This gene encodes one of the mitochondrial translation elongation factors, which is a GTPase that plays a role at the termination of mitochondrial translation by mediating the disassembly of ribosomes from messenger RNA . Its role in the regulation of normal mitochondrial function and in disease states attributed to mitochondrial dysfunction is not known. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2013]
GFM2 Gene-Disease associations (from GenCC):
- combined oxidative phosphorylation deficiency 39Inheritance: AR Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Pathogenic. The variant received 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-74746137-CT-C is Pathogenic according to our data. Variant chr5-74746137-CT-C is described in ClinVar as Pathogenic. ClinVar VariationId is 440787.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GFM2 | NM_032380.5 | c.636delA | p.Glu213ArgfsTer3 | frameshift_variant | Exon 9 of 21 | ENST00000296805.8 | NP_115756.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000144 AC: 2AN: 1392692Hom.: 0 Cov.: 26 AF XY: 0.00000145 AC XY: 1AN XY: 690270 show subpopulations
GnomAD4 exome
AF:
AC:
2
AN:
1392692
Hom.:
Cov.:
26
AF XY:
AC XY:
1
AN XY:
690270
show subpopulations
African (AFR)
AF:
AC:
0
AN:
30298
American (AMR)
AF:
AC:
0
AN:
28884
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
23122
East Asian (EAS)
AF:
AC:
0
AN:
38546
South Asian (SAS)
AF:
AC:
0
AN:
72290
European-Finnish (FIN)
AF:
AC:
0
AN:
51810
Middle Eastern (MID)
AF:
AC:
0
AN:
5306
European-Non Finnish (NFE)
AF:
AC:
2
AN:
1085280
Other (OTH)
AF:
AC:
0
AN:
57156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Mitochondrial disease Pathogenic:1
Sep 15, 2017
Wellcome Centre for Mitochondrial Research, Newcastle University
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Combined oxidative phosphorylation deficiency 39 Pathogenic:1
Apr 19, 2019
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.